Yong-Bok Park

This inventor holds 10 USPTO granted patents. Top assignees: Korea Institute of Science and Technology, Korea Research Institute of Bioscience and Biotechnology. Active years: 1998-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong-Bok Park. Retrieved from https://idiyas.com/inventor/yong-bok-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 90.0

Average Co-Inventor Count = 14.1

ph-index = 6

Forward Citations = 401(Granted Patents)

Company Filing History:

6 out of 2,248

Korea Institute of Science and Technology

patents

4 out of 334

Korea Research Institute of Bioscience and Biotechnology

patents

Years Active: 1998-2003

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6562866 - Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin (2003-05-13),

2. 6509372 - Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin (2003-01-21),

3. 6465019 - Health-improving spice composition (2002-10-15),

4. 6313171 - Method for preventing or treating elevated blood lipid level-related diseases by administering cinnamic acid derivatives (2001-11-06),

5. 6165984 - Naringin and naringenin as inhibitors of acyl (2000-12-26),

6. 6133311 - Method for preventing or treating elevated blood lipid level-related (2000-10-17),

7. 6096364 - Method for lowering blood glucose level by the administration of (2000-08-01),

8. 5877208 - Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) (1999-03-02),

9. 5792461 - Citrus peel extract as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase (1998-08-11),

10. 5763414 - Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) (1998-06-09),

Title: **The Innovative Journey of Yong-Bok Park**

Introduction

Yong-Bok Park, a noted inventor from Daegu, South Korea, has made significant contributions to the field of biotechnology with a total of ten patents to his name. His work primarily focuses on methods for treating conditions related to elevated blood lipid levels, showcasing an exceptional blend of scientific knowledge and innovative thinking.

Latest Patents

Among his latest inventions, Park has developed a method for preventing or treating diseases related to elevated blood lipid levels by administering rutin and quercetin. This method involves the effective administration of these compounds to mammals, offering potential health benefits for managing blood lipid-related diseases. His innovative approaches in this area underline his commitment to advancing health science.

Career Highlights

Yong-Bok Park has had a distinguished career, having worked with reputable institutions such as the Korea Institute of Science and Technology and the Korea Research Institute of Bioscience and Biotechnology. His involvement with these prestigious organizations reflects his dedication to research and innovation in biotechnology.

Collaborations

Throughout his career, Park has collaborated with fellow researchers, including Song-Hae Bok and Tae-Sook Jeong. These collaborations have likely contributed to his success and the development of his patented techniques, highlighting the importance of teamwork in scientific advancements.

Conclusion

Yong-Bok Park’s journey as an inventor exemplifies the spirit of innovation in addressing significant health issues. With multiple patents and a strong professional background, he continues to make an impact in the field of biotechnology. His work not only advances scientific understanding but also holds the potential to improve health outcomes for many.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]